Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-01-05
2010-10-05
Robinson, Hope A (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S350000, C530S300000
Reexamination Certificate
active
07807624
ABSTRACT:
The present invention provides compositions and methods for an improved coating for medical devices. Provided is a biofunctional coating composition comprising at least one binding domain that has binding specificity for a surface material of a medical device, and at least one binding domain that has binding specificity for cells of endothelial cell lineage. Methods for coating a surface of a medical device, and for manufacturing of a medical device, comprise contacting the surface to be coated with the biofunctional coating material in an amount effective to form a coating, and may further comprise contacting the coated surface with cells of endothelial cell lineage to bind the cells of endothelial cell lineage to the coated surface.
REFERENCES:
patent: 5354736 (1994-10-01), Bhatnagar
patent: 5356433 (1994-10-01), Rowland et al.
patent: 5498538 (1996-03-01), Kay et al.
patent: 5622699 (1997-04-01), Ruoslahti et al.
patent: 5635482 (1997-06-01), Bhatnagar
patent: 5643712 (1997-07-01), Brasile
patent: 5744515 (1998-04-01), Clapper
patent: 5866363 (1999-02-01), Pieczenik
patent: 5929060 (1999-07-01), Araneo
patent: 6033719 (2000-03-01), Keogh
patent: 6071890 (2000-06-01), Scheule et al.
patent: 6140127 (2000-10-01), Sprague
patent: 6180084 (2001-01-01), Ruoslahti et al.
patent: 6262017 (2001-07-01), Dee et al.
patent: 6280760 (2001-08-01), Meyer et al.
patent: 6306365 (2001-10-01), Ruoslahti et al.
patent: 6436132 (2002-08-01), Patel et al.
patent: 6559126 (2003-05-01), Tournaire et al.
patent: 6733755 (2004-05-01), Tchistiakova et al.
patent: 6818620 (2004-11-01), Bhatnagar
patent: 6894022 (2005-05-01), Hubbell et al.
patent: 6897218 (2005-05-01), Casella et al.
patent: 6933281 (2005-08-01), Ruoslahti et al.
patent: 6974791 (2005-12-01), Wong et al.
patent: 7018615 (2006-03-01), Ruoslahti et al.
patent: 7030213 (2006-04-01), Pierschbacher et al.
patent: 7037332 (2006-05-01), Kutryk et al.
patent: 7060681 (2006-06-01), Hubbell et al.
patent: 7067619 (2006-06-01), Ruoslahti et al.
patent: 7208011 (2007-04-01), Shanley et al.
patent: 7238669 (2007-07-01), Bishop-Hurley et al.
patent: 7390526 (2008-06-01), Stupp et al.
patent: 7396656 (2008-07-01), Lin et al.
patent: 7544661 (2009-06-01), Stupp et al.
patent: 7597924 (2009-10-01), Kondyurin et al.
patent: 7608581 (2009-10-01), Hamilton et al.
patent: 7625552 (2009-12-01), Helmus et al.
patent: 7670605 (2010-03-01), Hubbell et al.
patent: 7700563 (2010-04-01), Pena et al.
patent: 7709439 (2010-05-01), Helmus et al.
patent: 2003/0166004 (2003-09-01), Gyuris et al.
patent: 2003/0185870 (2003-10-01), Grinstaff et al.
patent: 2003/0203038 (2003-10-01), Vail
patent: 2003/0229393 (2003-12-01), Kutryk et al.
patent: 2004/0127640 (2004-07-01), Belcher et al.
patent: 2004/0258726 (2004-12-01), Stupp et al.
patent: 2005/0085623 (2005-04-01), Balian
patent: 2005/0187162 (2005-08-01), Dhanaraj
patent: 2005/0271701 (2005-12-01), Cottone, Jr. et al.
patent: 2006/0121012 (2006-06-01), Kutryk et al.
patent: 2006/0123505 (2006-06-01), Kikuchi et al.
patent: 2006/0135476 (2006-06-01), Kutryk et al.
patent: 2006/0153775 (2006-07-01), Von Wronski et al.
patent: 2006/0160743 (2006-07-01), Zhang et al.
patent: 2006/0223756 (2006-10-01), Liau et al.
patent: 2007/0050007 (2007-03-01), Kondyurin et al.
patent: 2007/0104758 (2007-05-01), Hamilton et al.
patent: 2007/0160644 (2007-07-01), Kenan et al.
patent: 2007/0264227 (2007-11-01), Lutolf et al.
patent: 2008/0131425 (2008-06-01), Garcia et al.
patent: 2009/0319020 (2009-12-01), Kassab
patent: 2010/0023111 (2010-01-01), Kondyurin et al.
patent: WO2008008266 (2008-01-01), None
patent: WO2009026158 (2009-02-01), None
Binetruy-Tournaire et al., “Identification of a peptide blocking VEGF-meidated angiogenesis”; EMBO Journal, vol. 19, No. 7, pp. 1525-1533, 2000.
Giordano et al., “Biopanning and rapid analysis of selective interactive ligands”; Nature Medicine, vol. 7, No. 11, pp. 12491253, 2001.
Hetian et al., “A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of VEGF to its kinase domain receptor”; Journal of Biological Chemistry, vol. 277, No. 45, pp. 43137-43142, 2002.
El-Mousawi et al., “A VEGF high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display library”; Journal of Biological Chemistry, vol. 278, No. 21, pp. 46681-46691, 2003.
Zhi et al. “Characterization of a specific phage-displayed peptide binding to vasculature of human gastric cancer”; Cancer Biology & Therapy, vol. 3, No. 12, pp. 1232-1235, 2004.
D'Andrea et al., “Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide”; PNAS, vol. 102, No. 40, pp. 14215-14220, 2005.
Guo et al., “Identification of peptides inhibiting adhesion of monocytes to the injured vascular endothelial cells through phage-displaying screening”; Acta Biochim Biophys Sina (Shanghai), vol. 37, No. 4, pp. 227-233, 2005.Note: only Abstract was available.
Whaley et al., “Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly”; Nature, 405: 665-668, 2000.
Gilbert et al., “Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion”; The Journal of Biological Chemistry, 275(21): 16213-16218, 2000.
Written Opinion of the International Searching Authority for PCT/US08/61200, Sep. 29, 2008.
Liang et al., “Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer”; Journal of Molecular Medicine, 84: 764-773, 2006.
Harris et al., “Staphylococcus aureusadhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(l-lysine)-grafted-poly(ethylene glycol) copolymers”; Biomaterials, 25: 4135-4118, 2004.
Griese et al., “Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy”; Circulation, 108: 2710-2715, 2003.
Werner et al., “Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury”; Circulation Research, 93: e17-24, 2003.
Walter et al., “Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells”; Circulation, 105: 3017-3024, 2002.
Kaushal et al., “Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo”; Nature Medicine, 7(9): 1035-1040, 2001.
Lefkowitz and Willerson, “Prospects for cardiovascular research”; JAMA, 285: 581-587, 2001.
Bhattacharya et al., “Enhanced endothelialization and mirovessel formation in polyester grafts seeded with CD34(+) bone marrow cells”; Blood, 95: 581-585, 2000.
Topol and Seruys, “Frontiers in interventional cardiology”; Circulation, 98: 1802-1820, 1998.
Written Opinion for the International Searching Authority for PCT/US08/80321, Mar. 17, 2009.
Hamilton Paul Theodore
Kenan Daniel James
Affinergy, Inc.
Kiefer Laura L.
Robinson Hope A
LandOfFree
Methods and compositions for promoting attachment of cells... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for promoting attachment of cells..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for promoting attachment of cells... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4212663